Pharmaceutical and biotechnology companies have great responsibility for re-taking back the human health and well-being. It is crucial for them to make sure that their
In this article, we delve deeper into the ways in which a provider of quality and regulatory consulting services can assist in transferring technology between
Specialists in the Life Science Industry from Compliance and other consulting firms provide this valuable guidance to Biologics manufacturers on their challenging journey. Problems
Overcoming the Mount Everest of Scale-Up Challenges in mRNA Therapeutics Manufacturing for Better Global Health Outcomes The universe of mRNA therapeutics manufacturing glows as a
The objective of these guidelines is to outline the minimum stability data package required for registration of Active Pharmaceutical Ingredients (APIs) and Finished Pharmaceutical Products
In the remarkable backdrop of challenges, the fate of the life sciences industry might be significantly determined by how international cooperation in mRNA vaccine regulation
Realizing the promise of gene therapy for neurodegenerative disease Introduction In a groundbreaking move for the life sciences sector, FDA released long-awaited guidance on gene
Discover the ICH S12 guidelines for nonclinical biodistribution (BD) testing of gene therapy products. Learn how BD data supports clinical trial design and safety assessments,
Over time the Bio-Boston industry policy advisers have served as trusted partners, endeavoring to solve key problems for these rapidly growing firms that are forced
Free Resources Unlocking Food Safety: A Guide to HACCP Principles Protecting the integrity and quality of food products is critical in a rapidly changing industry